Methane

Methane

SCHEMBL2993577

C.COC(=O)CCCOc1ccc(-c2ccc(C(C3CCNC3=O)C3C4CC5CC(C4)CC3C5)c(Cl)c2)cc1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
PDE3B Q13370 7/20 0.35
PDE3A Q14432 7/20 0.35
P2RY12 Q9H244 6/20 0.35
MAPT P10636 1/20 0.34
FFAR1 O14842 2/20 0.33
FFAR4 Q5NUL3 2/20 0.33
SCN9A Q15858 1/20 0.33
PDE2A O00408 1/20 0.32
REN P00797 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
PABPC1 P11940 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PRKAB2 O43741 1/20 0.31
PRKAG1 P54619 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5131935 0.91 FFAR4 (0.40) FFAR1FFAR4PRKAB2PRKAG1PRKAA2
SCHEMBL3002787 0.86 MEN1 (0.37) KDM4EPDE3BPDE3AP2RY12MAPT
SCHEMBL2998775 0.79 MEN1 (0.38) KDM4EPDE3BPDE3AP2RY12MAPT
SCHEMBL3548869 0.76 FFAR4 (0.42) PDE3BPDE3AP2RY12FFAR1FFAR4
SCHEMBL2986722 0.73 SLC6A3 (0.39) MAPTHSD17B10KMT2A
SCHEMBL3554796 0.69 FFAR4 (0.41) PDE3BPDE3AP2RY12FFAR1FFAR4
SCHEMBL4697044 0.69 PDE3B (0.43) KDM4EPDE3BPDE3AP2RY12PDE2A
SCHEMBL3551305 0.69 FFAR4 (0.42) KDM4EPDE3BPDE3AP2RY12FFAR1
SCHEMBL2999221 0.66 MMP2 (0.41) MAPTFFAR1FFAR4HSD17B10ALDH1A1
SCHEMBL5503358 0.65 PTGS2 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2010-07-22 US disclosed
US-7713979-B2 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-05-11 US disclosed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSDL2, HSD17B1 KDM4E 2842/4885PDE3B 766/4885PDE3A 709/4885
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 KDM4E 1996/4885PDE3B 215/4885PDE3A 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.